Survival Outcomes of a Large Cohort of Acral Melanoma Patients Treated at a South African Referral Hospital

Acral melanoma (AM) is the most common type of melanoma arising in people with skin of color. AM is often diagnosed late and associated with poor outcomes. Melanoma outcomes are also impacted by socioeconomic status. Although uncommon, AM is a public health concern in South Africa because of its epi...

Full description

Saved in:
Bibliographic Details
Main Authors: Bianca Tod, Tonya Esterhuizen, Willem Visser, Maritha Kotze, Anne Bowcock, Johann Schneider, Henriette Burger
Format: Article
Language:English
Published: Wiley 2025-01-01
Series:Journal of Skin Cancer
Online Access:http://dx.doi.org/10.1155/jskc/4779587
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832576743372750848
author Bianca Tod
Tonya Esterhuizen
Willem Visser
Maritha Kotze
Anne Bowcock
Johann Schneider
Henriette Burger
author_facet Bianca Tod
Tonya Esterhuizen
Willem Visser
Maritha Kotze
Anne Bowcock
Johann Schneider
Henriette Burger
author_sort Bianca Tod
collection DOAJ
description Acral melanoma (AM) is the most common type of melanoma arising in people with skin of color. AM is often diagnosed late and associated with poor outcomes. Melanoma outcomes are also impacted by socioeconomic status. Although uncommon, AM is a public health concern in South Africa because of its epidemiology and association with health access issues, which predispose to late diagnosis. South African patients are managed based on staging systems and treatment guidelines developed for other populations. This cohort study aimed to determine the survival outcomes in a cohort of South African AM patients and how these were associated with demographic, clinical, pathological, and management data. The study included patients diagnosed at a referral hospital between 1 January 2010 and 31 December 2021. Analysis occurred in 2022 and 2023. The main outcomes of interest were survival time in months (overall and progression-free, OS and PFS). Survival outcomes were analyzed using Kaplan–Meier survival curves. Survival probabilities were compared between subgroups using log-rank tests. Univariate and multivariable analyses were performed using the Cox proportional hazards models to assess factors associated with survival. Ninety-one patients were included in the analysis. After a median follow-up of 28 months (range: 0–151 months), 48 patients (52.7%) had died. The 3- and 5-year survival rates for the entire cohort were 64.8% and 56.0% respectively. Notably, the OS and PFS were not affected by the population group (p value = 0.628, not significant). The examination of OS and PFS by the clinical stage group demonstrated proportional hazard. Although SLNB comprised a small group, the results appear to be prognostically valid, specifically for OS. The results indicate that the AJCC eighth edition staging is broadly applicable to AM in this population; however, a rigorous comparison was not possible. SLNB appears to be prognostically valid. No difference in survival outcomes by population group was shown.
format Article
id doaj-art-2c95af5f72a14109a12bc315818e2d20
institution Kabale University
issn 2090-2913
language English
publishDate 2025-01-01
publisher Wiley
record_format Article
series Journal of Skin Cancer
spelling doaj-art-2c95af5f72a14109a12bc315818e2d202025-01-31T00:00:03ZengWileyJournal of Skin Cancer2090-29132025-01-01202510.1155/jskc/4779587Survival Outcomes of a Large Cohort of Acral Melanoma Patients Treated at a South African Referral HospitalBianca Tod0Tonya Esterhuizen1Willem Visser2Maritha Kotze3Anne Bowcock4Johann Schneider5Henriette Burger6Division of DermatologyDivision of Epidemiology and BiostatisticsDivision of DermatologyDivision of Chemical PathologyDepartments of DermatologyDivision of Anatomical PathologyDivision of Radiation OncologyAcral melanoma (AM) is the most common type of melanoma arising in people with skin of color. AM is often diagnosed late and associated with poor outcomes. Melanoma outcomes are also impacted by socioeconomic status. Although uncommon, AM is a public health concern in South Africa because of its epidemiology and association with health access issues, which predispose to late diagnosis. South African patients are managed based on staging systems and treatment guidelines developed for other populations. This cohort study aimed to determine the survival outcomes in a cohort of South African AM patients and how these were associated with demographic, clinical, pathological, and management data. The study included patients diagnosed at a referral hospital between 1 January 2010 and 31 December 2021. Analysis occurred in 2022 and 2023. The main outcomes of interest were survival time in months (overall and progression-free, OS and PFS). Survival outcomes were analyzed using Kaplan–Meier survival curves. Survival probabilities were compared between subgroups using log-rank tests. Univariate and multivariable analyses were performed using the Cox proportional hazards models to assess factors associated with survival. Ninety-one patients were included in the analysis. After a median follow-up of 28 months (range: 0–151 months), 48 patients (52.7%) had died. The 3- and 5-year survival rates for the entire cohort were 64.8% and 56.0% respectively. Notably, the OS and PFS were not affected by the population group (p value = 0.628, not significant). The examination of OS and PFS by the clinical stage group demonstrated proportional hazard. Although SLNB comprised a small group, the results appear to be prognostically valid, specifically for OS. The results indicate that the AJCC eighth edition staging is broadly applicable to AM in this population; however, a rigorous comparison was not possible. SLNB appears to be prognostically valid. No difference in survival outcomes by population group was shown.http://dx.doi.org/10.1155/jskc/4779587
spellingShingle Bianca Tod
Tonya Esterhuizen
Willem Visser
Maritha Kotze
Anne Bowcock
Johann Schneider
Henriette Burger
Survival Outcomes of a Large Cohort of Acral Melanoma Patients Treated at a South African Referral Hospital
Journal of Skin Cancer
title Survival Outcomes of a Large Cohort of Acral Melanoma Patients Treated at a South African Referral Hospital
title_full Survival Outcomes of a Large Cohort of Acral Melanoma Patients Treated at a South African Referral Hospital
title_fullStr Survival Outcomes of a Large Cohort of Acral Melanoma Patients Treated at a South African Referral Hospital
title_full_unstemmed Survival Outcomes of a Large Cohort of Acral Melanoma Patients Treated at a South African Referral Hospital
title_short Survival Outcomes of a Large Cohort of Acral Melanoma Patients Treated at a South African Referral Hospital
title_sort survival outcomes of a large cohort of acral melanoma patients treated at a south african referral hospital
url http://dx.doi.org/10.1155/jskc/4779587
work_keys_str_mv AT biancatod survivaloutcomesofalargecohortofacralmelanomapatientstreatedatasouthafricanreferralhospital
AT tonyaesterhuizen survivaloutcomesofalargecohortofacralmelanomapatientstreatedatasouthafricanreferralhospital
AT willemvisser survivaloutcomesofalargecohortofacralmelanomapatientstreatedatasouthafricanreferralhospital
AT marithakotze survivaloutcomesofalargecohortofacralmelanomapatientstreatedatasouthafricanreferralhospital
AT annebowcock survivaloutcomesofalargecohortofacralmelanomapatientstreatedatasouthafricanreferralhospital
AT johannschneider survivaloutcomesofalargecohortofacralmelanomapatientstreatedatasouthafricanreferralhospital
AT henrietteburger survivaloutcomesofalargecohortofacralmelanomapatientstreatedatasouthafricanreferralhospital